Drugs like semaglutide and tirzepatide have shown significant benefits for both type 2 diabetes and obesity
Some plans cover brand-name medications (Wegovy, Zepbound) prescribed via telehealth, though prior authorization is typically required
Top 10 Holdings 64.68% of assets Dividend History Performance OZEM had a total return of 22.47% in the past year, including dividends
Rosenstock stated in the Regeneron press release: These complete 26-week COURAGE results demonstrate a meaningful opportunity to preserve muscle mass while enhancing fat loss. Also noted: Numerical improvements in metabolic and lipid parameters, secondary and exploratory endpoints, were seen across all treatment groups, including improvements in waist circumference, blood pressure, cholesterol, triglycerides and A1C. Read the full press release:
RESEARCH PEPTIDES SOUTH AFRICA IS NOT ABLE TO ASSIST WITH THIS AND CANNOT SUPPLY THIS ITEM FOR USE IN THIS WAY WITHOUT VALID DOCTORS SCRIPT AND AUTHORIZATION